Preclinical data suggest that Moderna’s mpox vaccine could be superior to other alternatives currently approved, according to new research published Wednesday.
Scientists
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Last January, I went to fill my son’s ADHD prescription and was handed a bag with an unfamiliar drug name on it. No mistake, the
Boehringer Ingelheim is paying up to $1.3 billion to acquire a relatively unknown immuno-oncology biotech out of La Jolla, CA. The German drug giant …
Biomedical engineers at Duke University have significantly enhanced the capabilities of a computational model that simulates the movement of individual cancer cells across long distances